THE POSSIBILITIES OF USING THE PEPTIDE COMPLEX PROTECTOR 3 PLUS

DOI: https://doi.org/10.29296/25877305-2022-05-14
Issue: 
5
Year: 
2022

T. Potupchik, Candidate of Medical Sciences(1); A. Yashin(2)
1-V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia
2-Saint Petersburg Institute of Bioregulation and Gerontology

The article describes the role of peptide bioregulators in maintaining the structural and functional homeostasis of the body. The features of the use of peptide complexes with high antioxidant activity, anti-inflammatory, immunostimulating and antistress effects are presented. The peptide complex PROTECTOR 3 Plus, characterized by a high safety profile, can be recommended for improving the immune and endocrine systems at any age, improving the quality of sleep and emotional state, with asthenic disorders, including postcovid syndrome; in the complex therapy of cancer patients.
Keywords: 
therapy
peptide complexes
PROTECTOR 3 Plus
peptides of thymus
epiphysis
bone marrow

References: 
  1. Arushanyan E.B. Epiphysis hormone melatonin and its therapeutic possibilities. Russian Medical Journal. 2005; 26: 1755 (in Russ.).
  2. Breusenko D.V., Dimov I.D., Klimenko E.S. et al. Modern ideas about the morphology of the thymus. Pediatrician. 2017; 8 (5): 91–5 (in Russ.). DOI: 10.17816/PED8591-95
  3. Vasendin D.V. Medico-biological effects of melatonin: some results and prospects of study. Bulletin of the Russian Military Medical Academy. 2016; 3 (55): 171–8 (in Russ.).
  4. Gavrilova T.V., Gein O.N., Gein S.V. et al. Myelopeptides in the regulation of functional activity of macrophages under stress in vivo. Bulletin of the Perm Federal Research Center. 2020; 1: 53–9 (in Russ.). DOI: 10.7242/2658-705X/2020.1.6
  5. Gutop E.O., Linkova N.S., Fridman N.V. et al. The AED peptide activates gene expression and synthesis of human fibroblast differentiation proteins during replicative aging. Molecular medicine. 2022; 20 (2): 32–8 (in Russ.). DOI: 10.29296/24999490-2022-02-05
  6. Zakharov A.V., Khivintseva E.V., Pytin V.F. et al. Melatonin – known problems and perspectives of clinical usage. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2017; 117 (4-2): 74–8 (in Russ.). DOI: 10.17116/jnevro20171174274-78
  7. How Havinson peptides work (in Russ.). URL: https://www.vitual.ru/
  8. Lazebnik L.B., Radchenko V.2G., Dzhadhav S.N. et al. Systemic inflammation and non-alcoholic fatty liver disease. Experimental and Clinical Gastroenterology. 2019; 165 (5): 29–41. (in Russ.). DOI: 10.31146/1682-8658-ecg-165-5-29-41
  9. Maksutova G.I. The role of the epiphysis in the regulation of psychophysiological functions of the body. International Journal of Applied and Fundamental Research. 2016; 6-3: 485–7 (in Russ.).
  10. Potupchik T.V., Veselova O.F., Evert L.S. et al. Peptide bioregulators in locomotor apparatus injuries. Vrach. 2016; 7: 21–5 (in Russ.).
  11. Potupchik T., Veselova O., Evert L. et al. Application of peptide bioregulators in case of physical excretion. Sports medicine: research and practice. 2017; 7 (1): 53–9 (in Russ.). DOI: 10.17238/ISSN2223-2524.2017.1.53
  12. Potupchik T.V., Veselova O.F., Evert L.S. et al. Use of Vivax dent peptide bioregulators in dental practice. Meditsinskaya sestra. 2015; 5: 28–31 (in Russ.).
  13. Khavinson V.X., Kuznik B.I., Ryzhak G.A. Peptide bioregulators – a new class of geroprotectors. The results of experimental studies. The successes of gerontology. 2012; 4: 696–798 (in Russ.).
  14. Khavinson V.H., Popovich I.G. Pineal peptides and their role in ageing. Pathogenesis. 2017; 15 (3): 12–9 (in Russ.). DOI: 10.25557/GM.2017.3.8493
  15. Khavinson V.H., Soloviev A.Yu., Tarnovskaya S.I. et al. Mechanisms of biological activity of short peptides: penetration into the cell and epigenetic regulation of gene expression. The successes of modern biology. 2013; 133 (3): 310–6 (in Russ.).
  16. Blask D.E., Dauchy R.T., Sauer L.A. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine. 2005; 27 (2): 179–88. DOI: 10.1385/ENDO:27:2:179
  17. Blask D.E., Sauer L.A., Dauchy R.T. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem. 2002; 2 (2): 113–32. DOI: 10.2174/1568026023394407
  18. Park S.Y., Jang W.J., Yi E.Y. et al. Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia. J Pineal Res. 2010; 48: 178–84. DOI: 10.1111/j.1600-079x.2009.00742.x
  19. Reiter R.J. Mechanisms of cancer inhibition by melatonin. J Pineal Res. 2004; 37 (3): 213–4.
  20. Sanchez-Hidalgo M., Lee M., de la Lastra C.A. et al. Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines. J Pineal Res. 2012; 53: 366–73. DOI: 10.1111/j.1600-079x.2012.01006.x
  21. Tkachenko Т.В., Bobrov А.P., Ryzhak G.A. Application of peptide bioregulators in complex therapy of oral mucous coat in older patient. Abstr. VI european congress «healthy and active ageingfor all europeans» International association of gerontology and geriatrics, 5–8 July, 2007. Adv Gerontol. 2007; 3: 192.
  22. Zhou Q., Gui S., Wang Y. Melatonin Inhibits the migration of human lung adenocarcinoma A549 cell lines involving JNK/MAPK pathway. PLoS One. 2014; 9: 101–32. DOI: 10.1371/journal.pone.0101132